BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Global Needle-free IV Connectors Market - Rise in Chronic Diseases to Boost Growth| Technavio

  Technavio market research analysts forecast the global needle-free IV connectors market to grow at a CAGR of close to 10% during the period 2018-2022, according to their latest report.

  April 29, 2018

   · 

  3 min read
• Pharm Country

  BD Launches BD FACSymphony™ High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types

  BD (Becton, Dickinson and Company) announced the launch of the BD FACSymphony™ system, a novel cell analyzer enabling the simultaneous measurement of up to 50 different characteristics of a single cell.

  April 29, 2018

   · 

  3 min read
• Business

  Marina Del Rey-Based Board-Certified Plastic Surgeon Grant Stevens, MD, FACS Named New President of the American Society for Aesthetic Plastic Surgery

  The American Society for Aesthetic Plastic Surgery (ASAPS) has announced the election of Grant Stevens, MD, FACS, a board-certified plastic surgeon in Marina del Rey, California, as its new President.

  April 29, 2018

   · 

  7 min read
• Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018

  Galapagos NV presents preclinical results showing broad beneficial effects on cartilage and bone with GLPG1972 in an osteoarthritis (OA) rat model at the Osteoarthritis Research Society International (OARSI) World Congress today in Liverpool, UK.

  April 29, 2018

   · 

  5 min read
• Drug Development

  ThromboGenics Initiates Phase 2 Clinical Study Evaluating anti-PlGF (THR-317) in combination with anti-VEGF (ranibizumab) for treatment of Diabetic Macular Edema (DME)

  ThromboGenics NV announces that it has successfully enrolled the first patient in a Phase 2 active-controlled, masked, multicenter study to evaluate the efficacy and safety of THR-317 administered in combination with ranibizumab (Lucentis®, Novartis), for the treatment of DME (NCT03499223).

  April 29, 2018

   · 

  4 min read
• Global Non-insulin Diabetes Therapeutics Market - Increasing Prevalence of Type 2 Diabetes to Boost Growth | Technavio

  Technavio’s latest market research report on the global non-insulin diabetes therapeutics market provides an analysis of the most important trends expected to impact the market outlook from 2018-2022.

  April 29, 2018

   · 

  4 min read